Northwest Biotherapeutics Inc (NWBO)
0.4721
-0.01
(-1.67%)
USD |
OTCM |
Apr 23, 16:00
Northwest Biotherapeutics Cash from Operations (TTM): -53.64M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -53.64M |
| September 30, 2023 | -45.53M |
| June 30, 2023 | -47.73M |
| March 31, 2023 | -51.05M |
| December 31, 2022 | -52.78M |
| September 30, 2022 | -55.17M |
| June 30, 2022 | -46.07M |
| March 31, 2022 | -38.02M |
| December 31, 2021 | -38.30M |
| September 30, 2021 | -37.26M |
| June 30, 2021 | -38.26M |
| March 31, 2021 | -37.80M |
| December 31, 2020 | -32.09M |
| September 30, 2020 | -27.87M |
| June 30, 2020 | -26.30M |
| March 31, 2020 | -29.65M |
| December 31, 2019 | -31.86M |
| September 30, 2019 | -40.06M |
| June 30, 2019 | -37.66M |
| March 31, 2019 | -39.55M |
| December 31, 2018 | -34.59M |
| September 30, 2018 | -35.20M |
| June 30, 2018 | -36.87M |
| March 31, 2018 | -29.00M |
| December 31, 2017 | -36.50M |
| Date | Value |
|---|---|
| September 30, 2017 | -35.80M |
| June 30, 2017 | -39.83M |
| March 31, 2017 | -50.34M |
| December 31, 2016 | -55.65M |
| September 30, 2016 | -64.78M |
| June 30, 2016 | -66.83M |
| March 31, 2016 | -79.72M |
| December 31, 2015 | -79.71M |
| September 30, 2015 | -75.08M |
| June 30, 2015 | -71.76M |
| March 31, 2015 | -61.60M |
| December 31, 2014 | -54.58M |
| September 30, 2014 | -50.58M |
| June 30, 2014 | -50.02M |
| March 31, 2014 | -41.28M |
| December 31, 2013 | -37.80M |
| September 30, 2013 | -31.45M |
| June 30, 2013 | -29.66M |
| March 31, 2013 | -26.29M |
| December 31, 2012 | -22.75M |
| September 30, 2012 | -19.06M |
| June 30, 2012 | -18.04M |
| March 31, 2012 | -16.75M |
| December 31, 2011 | -14.71M |
| September 30, 2011 | -10.30M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-55.17M
Minimum
Sep 2022
-26.30M
Maximum
Jun 2020
-40.37M
Average
-38.26M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |
| Oragenics Inc | -7.291M |